A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
Biotechnology | Chemical | Diagnostics | FDA | Infectious Disease | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
An international call-to-action issued to conduct the annual observance of World Lupus Day
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
The Division of Global Migration and Quarantine controlled quarantine issues in the U.S.
In 2004, The Division of Global Migration and Quarantine, part of the CDC’s National Center for Infectious Diseases,…
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Michael Smith Genome Science Centre sequenced the SARS genome
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list
On Mar. 18, 2003, Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list. Persons under quarantine…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | WHO
SARS (Severe Acute Respiratory Syndrome) was first discovered in Asia
On Mar. 6, 2003, the Singapore Ministry of Health (MOH) and the World Health Organization (WHO), announced they…
Severe Acute Respiratory Syndrome (SARS) was recognized
At t he end of February 2003, the World Health Organization (WHO) recognized Severe Acute Respiratory Syndrome (SARS)…
Public health officials were concerned about re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
The Institute for Collaborative Biotechnologies was founded
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
FDA | Infectious Disease | Polio | Vaccine
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
President Bush announced a major smallpox vaccination program
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
The Public Health Security and Bioterrorism Preparedness and Response Act (PL 107-188) was signed
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…
Diagnostics | Infectious Disease | Polio | Vaccine | WHO
The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…
Biotechnology | Diagnostics | FDA | Infectious Disease | Medicine | NIH | Plague | Radiology | Therapeutics | U.S. Congress
President Bush signed the Public Health Security and Bioterrorism Preparedness and Response Act into law
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Rotary International launched a second fundraising campaign to eradicate polio
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
World Health Organization confirmed an outbreak of Ebola in Gabon
On Dec. 12, 2001, the World Health Organization (WHO) confirmed an outbreak of Ebola in Gabon. The WHO…
Institute of Medicine called for creation of a national vaccine authority
On Nov. 5, 2001, following the events of September 11, the Institute of Medicine again called for creation…
The CDC learned of a domestic terrorism attack via anthrax sent through the mail
On Sept. 11, 2001, the U.S. Centers for Disease Control and Prevention (CDC) learned of a domestic terrorism…
Louis Stokes Laboratories was dedicated
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…
A combined hepatitis A inactivated and hepatitis B (recombinant) vaccine was licensed
On May 11, 2001, the Food and Drug Administration (FDA) licensed a combined hepatitis A and B vaccine…
The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines
In 2001, The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines tailored…